Diagnostic and Therapeutic Yield of Endoscopy in Patients with Elevated INR and Gastrointestinal Bleeding

American Journal of Medicine

Volumn 129, Issue 6, 2016, Pages 628-634

  Peloquin, Joanna M ^a   Seraj, Siamak M ^b   King, Lindsay Y ^c   Campbell, Emily J ^b   Ananthakrishnan, Ashwin N ^b   Richter, James M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Gastrointestinal bleeding; Supratherapeutic INR; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; WARFARIN; ANTICOAGULANT AGENT;

AGED; ANEMIA; ANGIODYSPLASIA; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; COLITIS; COLON CANCER; COLON DIVERTICULOSIS; COLON POLYP; COLONOSCOPY; DIAGNOSTIC PROCEDURE; DIEULAFOY DISEASE; DUODENITIS; DUODENUM ULCER; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS ULCER; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEMORRHOID; HOSPITAL READMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MALLORY WEISS SYNDROME; MELENA; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROCTITIS; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH EROSION; STOMACH POLYP; STOMACH ULCER; VARICOSIS; VIDEO CAPSULE ENDOSCOPY; ADVERSE EFFECTS; CAPSULE ENDOSCOPY; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; ELECTRONIC HEALTH RECORD; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; ANEMIA; ANTICOAGULANTS; CAPSULE ENDOSCOPY; DRUG THERAPY, COMBINATION; ELECTRONIC HEALTH RECORDS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LOGISTIC MODELS; MALE; MELENA; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; WARFARIN;

EID: 84960146466     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.11.030     Document Type: Article

References (16)

1. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 21 2007 2689 2696
2. C.P. Choudari, C. Rajgopal, and K.R. Palmer Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment Gut 35 4 1994 464 466
3. T.A. Rubin, M. Murdoch, and D.B. Nelson Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes Gastrointest Endosc 58 3 2003 369 373
4. C.N. Shim, H.S. Chung, J.C. Park, and et al. Is endoscopic therapy safe for upper gastrointestinal bleeding in anticoagulated patients with supratherapeutic international normalized ratios? Am J Ther Dec 9, 2013 [Epub ahead of print]
5. W. Qureshi, C. Mittal, I. Patsias, and et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation Am J Cardiol 113 4 2014 662 668
6. N. Sengupta, J.D. Feuerstein, V.R. Patwardhan, and et al. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study Am J Gastroenterol 110 2 2015 328 335
7. C. Chai-Adisaksopha, C. Hillis, M. Monreal, D.M. Witt, and M. Crowther Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis Thromb Haemost 114 4 2015 819 825
8. N.R. Desai, A.A. Krumme, S. Schneeweiss, and et al. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications Am J Med 127 11 2014 1075e1 1082e1
9. R. Nalichowski, D. Keogh, H.C. Chueh, and S.N. Murphy Calculating the benefits of a research patient data repository AMIA Annu Symp Proc 1044 2006
10. A. Di Minno, G. Spadarella, D. Prisco, A. Scalera, E. Ricciardi, and G. Di Minno Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: clinical translation and areas of research Blood Rev 29 5 2015 335 343
11. J.C. Lauffenburger, J.F. Farley, A.K. Gehi, D.H. Rhoney, M.A. Brookhart, and G. Fang Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study J Am Heart Assoc 4 4 2015 e001798
12. C.J. Anthony, S. Karim, S. Ackroyd-Stolarz, and et al. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department Ann Pharmacother 45 7-8 2011 881 887
13. K. Fitch, J. Broulette, and W.J. Kwong The economic burden of ischemic stroke and major hemorrhage in Medicare beneficiaries with nonvalvular atrial fibrillation: a retrospective claims analysis Am Health Drug Benefits 7 4 2014 200 209
14. D.L. Bhatt, J. Scheiman, N.S. Abraham, and et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 52 18 2008 1502 1517
15. C. Mo, G. Sun, Y.Z. Wang, M.L. Lu, and Y.S. Yang PPI versus histamine H2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: systematic review and meta-analysis PLoS One 10 7 2015 e0131558
16. A. Clemens, A. Strack, H. Noack, S. Konstantinides, M. Brueckmann, and G.Y. Lip Anticoagulant-related gastrointestinal bleeding - could this facilitate early detection of benign or malignant gastrointestinal lesions? Ann Med 46 8 2014 672 678